Shona C Fang – Boston Collaborative Drug Surveillance Program (BCDSP)

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

By BCDSP February 10, 2017Drug Safety Studies, Safety of other important drugs, Select Publications

Journal: Clinical Epidemiology Authors: Katrina Wilcox Hagberg, Hozefa A Divan, Shona C Fang, J Curtis Nickel, Susan S Jick 1 NLM Citation: Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS. Risk of gynecomastia…